Colloidal osmotic pressure (COP)

Colloidal osmotic pressure (COP), also known as oncotic pressure, is a form of osmotic pressure exerted by proteins, particularly albumin, in the blood plasma (StatPearls, Physiology, Oncotic Pressure, 2023). It serves as a primary force in the Starling equation, counteracting hydrostatic pressure to retain fluid within the vascular compartment and prevent excessive leakage into the interstitial space (NCBI, Starling Equation, 2022). In clinical settings, COP is a critical parameter in managing fluid balance; a decrease in COP, often due to hypoalbuminemia, leads to the development of edema and effusions (Journal of Intensive Care, 2018). Therapeutic intervention involves the administration of colloid solutions, such as albumin or synthetic starches, to restore intravascular volume and stabilize hemodynamics in patients with shock or severe protein loss. However, the use of certain synthetic colloids is associated with significant safety concerns, including risks of acute kidney injury and coagulopathy (PubMed, Colloids vs Crystalloids, 2013).

Other names

Oncotic pressurePlasma oncotic pressureProtein osmotic pressure

Colloid drugs increase the concentration of large, non-diffusible particles in the plasma, thereby increasing the osmotic gradient to draw or retain fluid within the intravascular space (StatPearls, Physiology, Oncotic Pressure, 2023).